Clinical validity of the Mattis Dementia Rating Scale-2 in Parkinson disease with MCI and dementia.
about
Normative data for the Dementia Rating Scale-2 in the French-Quebec population.Therapeutic development paths for cognitive impairment in Parkinson's disease: report of a regulatory roundtableLongitudinal study of normal cognition in Parkinson disease.Screening for Mild Cognitive Impairment in Parkinson's Disease: Comparison of the Italian Versions of Three Neuropsychological Tests.DEVELOPMENT OF CLINICAL DEMENTIA RATING SCALE CUTOFF SCORES FOR PATIENTS WITH PARKINSON'S DISEASE.APOE, MAPT, and COMT and Parkinson's Disease Susceptibility and Cognitive Symptom Progression.Remission of cognitive deficits in Parkinson's disease: recovery from a nonamnestic mild cognitive impairment or psychiatric symptoms remission?The Movement Disorders Society criteria for the diagnosis of Parkinson's disease dementia: their usefulness and limitations in elderly patients.Global scales for cognitive screening in Parkinson's disease: Critique and recommendations.Spanish version of the Mattis Dementia Rating Scale-2 for early detection of Alzheimer's disease and mild cognitive impairment.Role of clinical neuropsychology in deep brain stimulation: Review of the literature and considerations for clinicians.Rivastigmine for mild cognitive impairment in Parkinson disease: a placebo-controlled study.Behavioral Ratings of Executive Functioning Explain Instrumental Activities of Daily Living beyond Test Scores in Parkinson's Disease.Lifetime exposure to estrogen and progressive supranuclear palsy: Environmental and Genetic PSP study.Screening for Mild Cognitive Impairment Using the Dementia Rating Scale-2.Accuracy of Two Cognitive Screening Tools to Detect Mild Cognitive Impairment in Parkinson's DiseaseAssessment of Metacognition and Reversal Learning in Parkinson's Disease: Preliminary Results
P2860
Q30661442-41C67600-2C37-4D69-8A62-6426836679E8Q35211545-BAD4FEC2-098A-485E-89FC-F66E77143354Q35771313-2E54EE5D-CAE0-4B81-BF42-CA64613BA5CEQ36304622-872B9416-7E69-498F-BE85-0569866869BEQ36362023-5F5FAE9F-0A07-4CC6-BFAA-E7CBF7D801AEQ40809659-1D88C384-902B-4FFE-9CB3-48A70B139F9CQ41529770-EAA85D40-0851-4AB8-AADE-CC44DE7679E7Q44300930-4A070C4E-5AA4-4D84-BD42-F3990B0012A3Q47423910-9E39994D-BEFB-4B56-A5A1-5B3526E5B3ECQ47769066-E7615109-6A46-4B48-A760-738EB5E2C32DQ47918128-91EC601E-B4F8-4038-9D0B-4D65D95D4C96Q48084523-F556E621-4C3C-4870-A861-59C5BD754176Q48961291-F02769F4-4E92-4937-9E20-AB88D462ECDBQ49817768-D5F3F626-37FB-4F97-BE53-46F01F9950D7Q50657593-76441402-E7C7-400C-89FF-BFFFEAFF7C0EQ58575500-CCE60FD4-9515-4961-B6D6-6980570BAE3DQ58750796-EC4C9EE3-ABE2-4939-94D8-E8E6273D73EB
P2860
Clinical validity of the Mattis Dementia Rating Scale-2 in Parkinson disease with MCI and dementia.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Clinical validity of the Matti ...... disease with MCI and dementia.
@en
Clinical validity of the Matti ...... disease with MCI and dementia.
@nl
type
label
Clinical validity of the Matti ...... disease with MCI and dementia.
@en
Clinical validity of the Matti ...... disease with MCI and dementia.
@nl
prefLabel
Clinical validity of the Matti ...... disease with MCI and dementia.
@en
Clinical validity of the Matti ...... disease with MCI and dementia.
@nl
P2093
P2860
P356
P1476
Clinical validity of the Matti ...... disease with MCI and dementia.
@en
P2093
Evelyne Matteau
Mélanie Langlois
Nicolas Dupré
Pierre Provencher
P2860
P304
P356
10.1177/0891988712445086
P577
2012-06-01T00:00:00Z